Free Trial

NKGen Biotech (NKGN) Short Interest Ratio & Short Volume

NKGen Biotech logo
$0.17 0.00 (0.00%)
As of 08/6/2025

NKGen Biotech Short Interest Data

NKGen Biotech (NKGN) has a short interest of 697,300 shares. This marks a 49.22% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.5, indicating that it would take 2.5 days of the average trading volume of 1.70 million shares to cover all short positions.

Current Short Interest
697,300 shares
Previous Short Interest
467,300 shares
Change Vs. Previous Month
+49.22%
Dollar Volume Sold Short
$195.24 thousand
Short Interest Ratio
2.5 Days to Cover
Last Record Date
July 15, 2025
Outstanding Shares
44,948,000 shares
Percentage of Shares Shorted
1.55%
Today's Trading Volume
70 shares
Average Trading Volume
1,704,274 shares
Today's Volume Vs. Average
0%
Short Selling NKGen Biotech?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for NKGen Biotech and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

NKGN Short Interest Over Time

NKGN Days to Cover Over Time

NKGN Percentage of Float Shorted Over Time

NKGen Biotech Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/2025697,300 shares $195.24 thousand +49.2%N/A2.5 $0.28
6/30/2025467,300 shares $154.21 thousand +14.0%1.2%1.5 $0.33
6/15/2025410,000 shares $135.30 thousand +221.1%1.0%1.4 $0.33
5/31/2025127,700 shares $36.79 thousand -5.6%0.3%0.4 $0.29
5/15/2025135,200 shares $44.28 thousand +349.2%N/A0.2 $0.33
4/30/202530,100 shares $4.95 thousand -65.6%N/A0.2 $0.16
4/15/202587,400 shares $11.38 thousand +5.6%N/A0.3 $0.13
3/14/2025243,000 shares $41.26 thousand -82.9%N/A0.1 $0.17
2/14/20251,510,000 shares $952.81 thousand +189.8%5.4%0.4 $0.63
1/31/2025521,000 shares $254.51 thousand -7.2%2.2%1 $0.49
1/15/2025561,300 shares $285.14 thousand -20.5%3.0%0.8 $0.51

NKGN Short Interest - Frequently Asked Questions

What is NKGen Biotech's current short interest?

Short interest is the volume of NKGen Biotech shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 697,300 shares of NKGN short. Learn More on NKGen Biotech's current short interest.

What is a good short interest ratio for NKGen Biotech?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NKGN shares currently have a short interest ratio of 2.0. Learn More on NKGen Biotech's short interest ratio.

Is NKGen Biotech's short interest increasing or decreasing?

NKGen Biotech saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 697,300 shares, an increase of 49.2% from the previous total of 467,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does NKGen Biotech's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to NKGen Biotech: Longeveron Inc. (5.20%), Cyclacel Pharmaceuticals, Inc. (7.79%), Aytu BioPharma Inc. (9.76%), Reviva Pharmaceuticals Holdings, Inc. (12.60%), Dare Bioscience, Inc. (12.74%), Calidi Biotherapeutics, Inc. (10.75%), Cadrenal Therapeutics, Inc. (1.53%), Lisata Therapeutics, Inc. (0.44%), Natural Alternatives International, Inc. (0.55%), VYNE Therapeutics Inc. (2.45%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks.

What does it mean to sell short NKGen Biotech stock?

Short selling NKGN is an investing strategy that aims to generate trading profit from NKGen Biotech as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against NKGen Biotech?

A short squeeze for NKGen Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NKGN, which in turn drives the price of the stock up even further.

How often is NKGen Biotech's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NKGN, twice per month. The most recent reporting period available is July, 15 2025.




This page (NYSE:NKGN) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners